Aspira Pathlab Diagnostics Ltd vs Kaya Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 43.3 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Kaya Ltd changed from 3.7 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 31.91 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Kaya Ltd changed from ₹ 409.69 crore on March 2024 to ₹ 361.84 crore on March 2026 . This represents a CAGR of -2.05% over 6 years The revenue of Aspira Pathlab & Diagnostics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Kaya Ltd for the Mar '26 is ₹ 61.54 crore as compare to the Dec '25 revenue of ₹ 61.7 crore. This represent the decline of -0.26% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Kaya Ltd for the Mar '26 is ₹ -6.94 crore as compare to the Dec '25 ebitda of ₹ -14.98 crore. This represent the decline of -53.67% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Kaya Ltd changed from ₹ 102.7 crore to ₹ -27.77 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kaya Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Kaya Ltd

Kaya Limited was formerly incorporated as Kaya Skin Care Limited on March 27, 2003.
The Company name was changed from Kaya Skin Care Limited to Kaya Limited in March, 2012.
The Company, headquartered in Mumbai, carries on Skin Care Business in India and through its subsidiary in Middle East region.
Up to March 31, 2013, the Kaya Business was conducted as subsidiaries of Marico Limited.
Following the demerger, of Kaya business from Marico Limited in September, 2013 the Kaya Business has been conducted by the Company and its subsidiaries. Kaya has pioneered into aesthetic dermatology in India and the Middle East.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Kaya Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Kaya Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Kaya Ltd is 426 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Kaya Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Kaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Kaya Ltd?

As of October 25, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Kaya Ltd stock price is INR ₹280.6.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Kaya Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Kaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.